Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors

Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors
Condition:   Advanced Solid Tumor
Intervention:   Biological: SON-1010
Sponsor:   Sonnet BioTherapeutics
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 30, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments